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Background: Although needle and syringe sharing is one of the main routs of transmission
of HIV in several countries in the middle east, very little is known about how socio-economic
status of injecting drug users (IDUs) is linked to the receptive syringe sharing behaviors in
these countries.
Aim: To study socio-economic correlates of receptive needle and syringe sharing among
IDUs in Iran.
Methods:The study used data from the Unhide Risk Study, a national survey of IDUs.This
study sampled 636 IDUs (91% male) via snowball sampling from eight provinces in Iran
in 2009. Socio-demographic and drug use characteristics were collected. We used a logis-
tic regression to determine factors associated with receptive needle and syringe sharing
during the past 6 months.
Results: From 636 IDUs enrolled in this study, 68% (n=434) reported receptive nee-
dle and syringe sharing behaviors in the past 6 months. Odds of receptive needle and
syringe sharing in the past 6 months was lower among IDUs who were male [odds ratios
(OR)=0.29, 95% confidence interval (CI)=0.12–0.70], had higher education (OR=0.74,
95% CI=0.64–0.86) but higher among those who were unemployed (OR=4.05, 95%
CI=1.50–10.94), and were single (OR=1.47, 95% CI=1.02–2.11).
Conclusion: This study presented factors associated with risk of receptive needle and
syringe sharing among Iranian IDUs. This information may be used for HIV prevention and
harm reduction purposes. Socio-economic status of Iranian IDUs may be closely linked to
high-risk injecting behaviors among them.
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INTRODUCTION
Increasing trend of HIV and AIDS is a global health challenge
(1). In several Middle Eastern countries, this epidemic is closely
attached to the pattern of high-risk injecting behaviors among
injecting drug users (IDUs) (2). In Iran, at least 6 of 10 HIV posi-
tive cases and 8 of 10 AIDS cases occur among IDUs (3). In Iran,
needle-sharing behaviors have been consistently shown to be a
main route of HIV transmission (4–8).
The Iranian Ministry of Health has recently announced an esti-
mated figure of 200,000 IDUs in Iran (9). Although Iran has a
number of harm reduction programs for tackling epidemics of
HIV and other blood born infections among IDUs and other high-
risk groups (6, 10–12), prevalence of HIV is increasing rapidly
among infections among IDUs in Iran (6). High prevalence of
HIV (10–20%) and HCV (30–50%) among Iranian drug injec-
tors is well known (13–18). High prevalence of HIV and other
blood born infections among Iranian IDUs have been attributed to
their high rate risk-behaviors such as shared injection and needle
sharing (3, 6–8, 19, 20).
Globally, rate of syringe sharing varies based on geographic
regions. Shared injecting behaviors have been reported to be from
25% in Canada (21) to 80% in Mexico (19). Prevalence of shared
injection among Iranian IDUs differs widely from one study to
another. Lifetime needle and syringe sharing among IDUs was
one-third among IDUs in 2009 (19), half in one national survey
in 1999 (20), and finally two-thirds in another study published in
2006 (5).
A wide range of socio-economic factors may be associated with
high-risk injecting behaviors among IDUs. Socio-demographic
characteristics such as gender (19),marital/partnership status (22),
employment (19), economic status (19), living condition (19), and
place of residence (23) may influence pattern of risk-behaviors
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among IDUs. In addition to the socio-economic factors, drug use
characteristics such as years passed from first drug injection (24),
frequency (21) and setting (25, 26) of injection, and poly drug use
(21) may influences high-risk injections of IDUs. HIV sero-status
and HIV knowledge may also contribute to high-risk injections of
IDUs (22).
In Iran, little is known about the socio-economic and drug-
related predictors of risk-behaviors among Iranian IDUs (3, 6,
7). A recent report suggested that female gender [odds ratios
(OR)= 2.68] and being jobless (OR= 1.87) were associated with
higher risk of shared injection, while being alone at most injections
(OR= 0.51) was associated with lower risk of needle and syringe
sharing (19). That study is, however, limited for two reasons. First,
the study entered other high-risk-behaviors to the list of predictors
of lifetime needle sharing in the model. Including other risk factors
may result in over adjustment or at least un-necessary adjustment
(27–29). Secondly, as outcome is lifetime needle and syringe shar-
ing history (19), we do not have information on receptive sharing
behaviors.
To set harm reduction policies, policy makers need information
on rate and associated factors of risky behavior. This study is thus
aimed to determine the rate and predictors of receptive needle and
syringe sharing among Iranian IDUs.
MATERIALS AND METHODS
DESIGN AND SETTING
With a cross-sectional design, data came from Unhide Risk, a
national survey of IDUs. This study sampled 636 IDUs (91%
male) via snow ball sampling from eight provinces in Iran in 2009.
Some other manuscripts have been published from this database
(30–32).
CODES OF ETHICS
The study was approved by the ethical review committee of the
Baqiyatallah University of Medical Sciences. Informed consent was
obtained from all the participants after they had been verbally reas-
sured that the information would be kept confidential, especially
from the correctional system. All questionnaires were anonymous.
No financial incentives were given to the participants, however, all
participants received HIV education, and also free syringes and
condoms.
PROCESS
Data were collected via structured interviews, using a question-
naire. Interviews were performed by research area specialists who
had received trainings through workshops held in Tehran, Iran.
Each interview took up to 60 min.
Data were collected using paper-based questionnaires, which
included: (1) socio-demographic, (2) family data, (3) history of
childhood trauma, (4) HIV attitude, (5) HIV knowledge, (6)
Injection Behavior, (7) sexual behavior, and (8) HIV test.
OUTCOME
Receptive needle and syringe sharing during the past 6 months was
measured using these two questions: (A) During the last month,
how many times did you inject drugs using shared syringe/needle?
Answers included (0) never, (1) only 1–3 times, (2) once a month,
(3) 2–3 times a month, (4) 1 time per week, (5) 2–6 times a week,
(6) 1 time per day, (7) 2–3 times a day,and (8) 4 times or more a day.
(B) During the past 6 months, provided that using shared syringes,
usually how many people had injected by that used syringe, before
your injection? Answer of 1 or more to both above questions were
considered as receptive needle sharing. The 6-month interval has
been used for assessing needle sharing, previously (22, 33).
STATISTICAL ANALYSIS
The data obtained in the Statistical Package for the Social Sciences
17 (SPSS Inc, IL, USA) for Windows. In addition to descriptive sta-
tistics that included mean and standard deviation (SD) and also
median and first and third quartile (25th and 75th percentiles).
For bivariate analysis, independent samples t -test, and chi-square
tests were used. Multivariate stepwise logistic regression was used
to determine the predictors of receptive syringe and needle shar-
ing. ORs and 95% Confidence Interval (CI) were reported. P value
<0.05 was considered significant.
RESULTS
All 636 participants were street-based IDUs, 71.5% of whom were
daily injectors (n= 455). 91.1% were male, 57.8% were single,
59.3% were employed, and only 8.3% were illiterate.
Mean age of the IDUs was 31.5± 7.8 year. Details of baseline
data are presented in Table 1.
RECEPTIVE NEEDLE AND SYRINGE SHARING BEHAVIORS
Two IDUs (0.3%) did not answer our questions regarding the
receptive sharing, and 68% of IDUs (n= 434) reported receptive
needle and syringe sharing.
Using the Pearson Chi-square test for bivariate analysis showed
that being female (OR= 1.07, 95% CI= 1.02–1.11), experience
of abuse during childhood (OR= 1.41, 95% CI= 1.23–1.61), and
unemployment (OR= 1.05, 95% CI= 1.01–1.08) were associated
with higher likelihood of receptive needle and syringe sharing.
There was not a significant association between received sharing
and living alone or being illiterate (p> 0.05 for all) (Table 2).
Based on the independent samples t -test, mean age was not
significantly different between those with (31.4± 7.9 years) and
without (31.6± 7.8 years) received needle sharing (p= 0.75).
Logistic regression showed that the likelihood of receptive nee-
dle and syringe sharing in that past 6 months was positively asso-
ciated with being jobless (OR= 4.05, 95% CI= 1.50–10.94), being
single (OR= 1.47, 95% CI= 1.02–2.11), and negatively associated
with male gender (OR= 0.29, 95% CI= 0.12–0.70), and hav-
ing a higher educational level (OR= 0.74, 95% CI= 0.64–0.86)
(Table 3).
DISCUSSION
According to the current study, in Iran, about two of three IDUs
report receptive needle and syringe sharing. Receptive needle and
syringe sharing seems to be higher among female, unemployed,
single, and less educated IDUs.
The rate reported in this study seems alarming and higher than
some previously reported rates (19, 20). Our report is very similar
to the rate reported by Day et al. on the patterns of drug use among
a sample of drug users and IDUs attending a general practice in
Iran in 2006 (5). That report however was a single center, in clini-
cal setting, reporting shared injection among IDUs (n= 292) who
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Table 1 | Socio-demographic and injection frequency among Iranian
IDUs (n=636).
Characteristics n %
Socio-demographic data
Gender
Male 581 91.1
Female 44 6.9
Missing 13 2.0
Marital status
Single 369 57.8
Married 262 41.1
Missing 7 1.1
Educational level
Illiterate 53 8.3
Primary 140 21.9
Guidance school 232 36.4
High school 95 14.9
High school diploma 90 14.1
University degree 21 3.5
Missing 6 0.9
Living status
Alone 102 16.0
With someone 531 83.2
Missing 5 0.8
Housing
Live in others house 335 52.5
Live in own/rental house 273 42.8
Missing 30 4.7
Employment
Jobless 234 36.7
Employed 378 59.3
Missing 26 4.1
Injection frequency
2–3 times a month 62 9.7
Once a week 53 8.3
2–6 times a week 67 10.5
Once a day 131 20.5
2–3 times a day 198 31.0
4 times or more a day 127 19.9
were limited from a clinical setting in the capital of Iran. Our rate
is, however, only receptive syringe sharing among a community
sample of IDUs (n= 636) enrolled from eight provinces and has
sampled setting.
There is scarce data on the rate, reasons, risk factors and conse-
quences of needle, and syringe sharing among Iranian IDUs. Based
on one study, half of the IDUs had shared injection parapherna-
lia 1–2 months prior to interview. Sharing in prisons was stated
to be the rule. Reasons for sharing were indicated as difficulty of
purchasing syringes in inaccessible hours, hesitance of pharma-
cists to sell syringes and also financial strains. The main reason for
avoiding sharing among IDUs was the fear of acquiring HIV (34).
A qualitative study of IDUs in Iran reported a possible reduc-
tion in the needle sharing. That study however showed that IDUs
Table 2 | Comparison of socio-demographic and injection frequency
among Iranian injection drug users with and without receptive
syringe sharing (n=636).
Receptive syringe
sharing
Sig.a
Yes N =434 No N =202
Female 38 (9.0) 6 (3.0) 0.006
Single 261 (61.0) 108 (53.7) 0.085
Unemployed 30 (6.9) 5 (2.5) 0.022
Lived alone 74 (17.1) 28 (13.9) 0.308
Positive history of childhood abuse 216 (51.1) 62 (31.0) <0.001
Daily injector 319 (73.5) 136 (67.3) 0.108
Illiterate 45 (10.4) 8 (4.0) 0.821
aChi-square test was employed.
Outcome was missed in two participants.
Table 3 | Summary of findings of binary logistic regression on
socio-economic and drug-related factors associated with receptive
syringe sharing among injection drug users (n=636).
Characteristics Exp (B) 95% C.I. for
Exp (B)
Lower Upper
Gender (male) 0.29 0.12 0.70
Marital status (single) 1.47 1.02 2.11
Higher educational level 0.74 0.64 0.86
Unemployment 4.05 1.50 10.94
Variable(s) entered on thismodel included age, gender, marital status, educational
level, unemployment, living alone, injection frequency, and history of childhood
abuse.
continue to share drugs in locations of group injection, and in
states of withdrawal or severe addiction. That qualitative study
stated being homeless, female, and young age as possible factors
that may increase the risks for HIV among IDUs. System-wise
barriers to harm reduction listed by participants included the cost
or stigma of purchasing needles from pharmacies, over-burdened
clinics, irregular enforcement of laws protecting IDU, and lack of
efforts to address the sexual risks of IDU (8).
In a recent national study on more than 2,000 IDUs in Iran
in 2007, lifetime needle and syringe sharing was associated with
female gender, being jobless, having illegal income, and history
of drug use by family members (35). The first two risk factors
reported by that study was also associated with a higher likelihood
of receptive syringe sharing among our sample. The outcome, was,
however, different in the two studies.
Our study showed a higher likelihood of receptive needle and
syringe sharing among female IDUs. Gender has been reported as
a factor associated with sharing behaviors in both Iran (35) and in
other countries (36, 37). A qualitative study of Iranian female IDUs
reported sharing syringes as a typical behavior of IDUs (6). As a
result, needle exchange programs need to be sensitive to gender of
the target IDU population (38).
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Based on the Theory of Gender and Power, the sexual division
of labor, the sexual division of power, and the structure of cathexis
are the main structures that influence distribution of risk based on
gender in a society. Based on this theory, which was developed by
Connell in 1987, major gender differences in employment, income,
and education may contribute to power imbalances and subordi-
nation of women in many aspects in most societies. Due to such
inequalities, women are more frequently exposed to risk factors
that ultimately influence their well-being (39).
In our study, compared to those with a job, unemployed IDUs
were at a higher risk of receptive needle and syringe sharing.
Review of literature shows a link between unemployment of IDUs
and needle and syringe sharing behavior (40, 41). This might be
a direct result of financial strains of unemployment, or a more
complex pathway, such as network or associated traits.
In Iran, evidences have shown that access to a needle and
syringe program will reduce the needle and syringe sharing prac-
tices of the IDUs (8). A quantitative study with cross-sectional
design reported that shared use of needle/syringe in the past
month was significantly lower among IDUs who received esti-
mated≥7 syringes per week than those who did not (OR= 14.36),
and the findings suggest that the outreach program in Tehran
has reduced direct sharing among those who received more than
several needles/syringes from the program (42). Another quanti-
tative study in 2005, on 419 street-based IDUs in Tehran compared
self-reported needle and syringe access and use between IDUs
from a neighborhood with an active NSP to IDUs from a neigh-
borhood without such an intervention. A significantly smaller
proportion of IDUs from the former neighborhood reported
having used a shared needle/syringe over a 1-month period
(21.0%) compared to IDUs from the latter neighborhood (39.9%)
(OR= 0.24). That study documented a success of the NSP pro-
grams in Iran in reducing needle and syringe sharing practices
among IDUs (8).
There are some limitations to this study. First, cross-sectional
design of the study limits any causal inference. Future research
should go beyond cross-sectional studies and test direction of the
associations reported in this study. We did not have data on social
context and social network of the IDUs. We also did not enter
access to needle exchange programs or HIV education programs to
our study. The study relies on participants’ self-report data, which
may be affected by response bias. Thus we cannot rule out the pos-
sibility of underreported shared injection due to social desirability
of the IDUs (43). As samples were not random, findings are not
representative of all IDUs.
CONCLUSION
Intervention programs that target to reduce HIV risk through pro-
motion of safe injection among Iranian IDUs should consider
socio-economic characteristics of their target populations. Such
programs may need to enhance enrolment of female, unemployed,
single, and less educated IDUs who are at highest risk of receptive
needle-sharing behaviors.
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